Vicky Bennett
banner
vickyb-micro.bsky.social
Vicky Bennett
@vickyb-micro.bsky.social
Research scientist for Amprologix at University of Plymouth
Interested in AMR, antimicrobial peptides, microbial genomics
Tries to write funny things about UTIs and infection control
Reposted by Vicky Bennett
We're proud to announce that Amprologix is one of the 103 finalists selected to participate in the MassChallenge Switzerland & UK Accelerator Programme 2025, chosen from a pool of 1,527 high-potential startups worldwide.
Amprologix Selected for MassChallenge Switzerland & UK 2025 Accelerator - Amprologix
Amprologix joins a global network of innovators We're proud to announce that Amprologix is one of the 103 finalists selected to participate in the MassChallenge Switzerland & UK Accelerator Programme ...
www.amprologix.com
July 16, 2025 at 4:58 PM
Reposted by Vicky Bennett
Epidermicin NI01, has been featured in EMJ Reviews following a presentation by CSO @matupton.bsky.social at @escmid.bsky.social Global 2025.

The data highlights efficacy in MRSA wound infections, and low risk of triggering allergic reactions - a promising step forward in the fight against AMR.
Epidermicin NI01, a First-in-Class Peptide Antibiotic Candidate, Has Potent Efficacy in a Robust MRSA Wound Infection Model and Low Allergic Reaction Liabilities
Over 10% of antibiotic prescriptions are for skin infections.1,2 New therapeutic approaches are required, and new modalities may be...
www.emjreviews.com
June 16, 2025 at 10:59 AM
Reposted by Vicky Bennett
@matupton.bsky.social, CSO, recently presented results from ongoing research at ESCMID Global 2025 - the Congress of the European Society of Clinical Microbiology and Infectious Diseases - in Vienna

www.plymouth.ac.uk/news/studies...
Studies shows new class of antibiotic is effective in tackling MRSA
University of Plymouth news: The latest results of ongoing research by the University, and spinout company Amprologix, will be presented to leading...
www.plymouth.ac.uk
May 21, 2025 at 8:45 AM
Reposted by Vicky Bennett
Genomics & phenotype of 3 Cupriavidus strains from cystic fibrosis lung - great team with PhD student Sean Kelly, @vickyb-micro.bsky.social @kmudz.bsky.social & clinical collaborators. High quality genomes, MDR to CF drugs, susceptible to pip/tazo & cefotax

academic.oup.com/jambio/artic...
Genomic insights and phenotypic characterization of three multidrug resistant Cupriavidus strains from the cystic fibrosis lung
AbstractAims. We aimed to investigate phenotypic and genomic traits of three Cupriavidus spp. isolates recovered from people with cystic fibrosis (PWCF). T
academic.oup.com
May 13, 2025 at 3:02 PM
Reposted by Vicky Bennett
Join us for 3 fun packed evenings at @bathbrewhouse to find out more about Our Bodies 👤🦵

Hear from researchers at the cutting edge of their fields, including @ella489.bsky.social and how she is making mini organs to study cancer! 🫀

🎟️ Tickets at pintofscience.co.uk/events/bath

#pint25
April 24, 2025 at 12:32 PM
First publication with new group in Plymouth! @kmudz.bsky.social

Highlights included the moment I discovered that Cupriavidus spp are in fact meant to have 2 chromosomes, so my 2 chromosome + 2 plasmid mega assembly wasn't a complete fail 💪

doi.org/10.1093/jamb...
Genomic insights and phenotypic characterisation of three multidrug resistant Cupriavidus strains from the cystic fibrosis lung
AbstractAims. We aimed to investigate phenotypic and genomic traits of three Cupriavidus spp. isolates recovered from people with cystic fibrosis (PWCF). T
doi.org
April 24, 2025 at 5:59 AM
Welcome to #MicroSky @katburdon.bsky.social 🤩

It was so lovely to see you at #Microbio25 and thanks for playing our buzz wire game ⚡⚡⚡
April 4, 2025 at 11:19 AM
April 3, 2025 at 12:18 PM